Podcast: Facilitating Patient Monitoring in CAR-T Development
In Partnership with Cerba Research
The US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out. Learn how molecular technology is enhancing patient safety for CAR-T clinical trials.
In Partnership with Cerba Research